FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...